(Q33348744)

English

Gemcitabine and cisplatin as induction chemotherapy for patients with unresectable Stage IIIA-bulky N2 and Stage IIIB nonsmall cell lung carcinoma: an Italian Lung Cancer Project Observational Study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Gemcitabine and cisplatin as induction chemotherapy for patients with unresectable Stage IIIA-bulky N2 and Stage IIIB nonsmall cell lung carcinoma: an Italian Lung Cancer Project Observational Study (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Federico Cappuzzo

object named as

Federico Cappuzzo

1

0 references

Giorgio Scagliotti

14

object named as

Giorgio V Scagliotti

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

7

object named as

Silvia Novello

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

author name string

Giovanni Selvaggi

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Vanesa Gregorc

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Francesca Mazzoni

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Maura Betti

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Maria Rita Migliorino

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Antonio Maestri

8

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Filippo De Marinis

9

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Samir Darwish

10

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Verena De Angelis

11

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Fabrizio Nelli

12

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Stefania Bartolini

13

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Maurizio Tonato

15

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Lucio Crinò

16

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

language of work or name

0 references

publication date

1 July 2003

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

98

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

128-134

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Chemotherapy plus radiotherapy compared with radiotherapy alone in the treatment of locally advanced, unresectable, non-small-cell lung cancer. A meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11460

21 January 2018

A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11460

21 January 2018

A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11460

21 January 2018

Revisions in the International System for Staging Lung Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11460

21 January 2018

Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11460

21 January 2018

Cisplatin-gemcitabine combination in advanced non-small-cell lung cancer: a phase II study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11460

21 January 2018

Weekly gemcitabine with monthly cisplatin: effective chemotherapy for advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11460

21 January 2018

Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11460

21 January 2018

Randomized phase III study of gemcitabine-cisplatin versus etoposide-cisplatin in the treatment of locally advanced or metastatic non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11460

21 January 2018

Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non-small-cell lung cancer: A randomized phase III study of the Italian Lung Cancer Project

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11460

21 January 2018

Gemcitabine and cisplatin as induction regimen for patients with biopsy-proven stage IIIA N2 non-small-cell lung cancer: a phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group (EORTC 08955).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11460

21 January 2018

A three-week schedule of gemcitabine-cisplatin in advanced non-small-cell lung cancer with two different cisplatin dose levels: a phase II randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11460

21 January 2018

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11460

21 January 2018

Gemcitabine and cisplatin in a multimodality treatment for locally advanced non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11460

21 January 2018

A 3-week schedule of gemcitabine plus cisplatin as induction chemotherapy for Stage III non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11460

21 January 2018

Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small-cell lung cancer: mature results of a phase II trial.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11460

21 January 2018

Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. Adopted on May 16, 1997 by the American Society of Clinical Oncology

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11460

21 January 2018

Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in stages IIIa and IIIb nonsmall cell lung cancer. A meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11460

21 January 2018

Randomized trial of neoadjuvant therapy for lung cancer: interim analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11460

21 January 2018

Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11460

21 January 2018

Survival of patients with resected N2 non-small-cell lung cancer: evidence for a subclassification and implications

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11460

21 January 2018

Identifiers

10.1002/CNCR.11460

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33348744&oldid=1767969275"